Oncoscience
Navigate
Submit an Article
Research Papers|Volume 13, Issue 0|pp. 35–43
Reduced immunogenicity of MYC amplified, metastatic prostate cancer
Back to articleFigure 2(2 of 3)
100%
Figure 2
Figure 2.Correlation of RNAseq values with tumor: blood sequencing read ratios for MYC, representing case IDs from the WCDT-MCRPC dataset(r = 0.442, p < 0.001) (Supplementary Table 6).